CD14, also known as the lipopolysaccharide (LPS) receptor, is a 53-55 kDa glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein. It is prominently expressed on the surface of monocytes and macrophages, and to a lesser extent on neutrophils . CD14 plays a crucial role in the immune system by recognizing and binding to LPS, a component of the outer membrane of Gram-negative bacteria, thereby initiating an immune response .
The CD14 Clone PAT87H7AT is a monoclonal antibody derived from the hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human CD14 protein . This clone is specifically designed to target human CD14, making it a valuable tool in immunological research and diagnostics.
CD14 is anchored to the cell membrane via a GPI linkage, which allows it to function as a high-affinity receptor for LPS-LBP (LPS-binding protein) complexes . Additionally, soluble forms of CD14 (sCD14) can also bind to LPS and act as an LPS agonist or antagonist depending on its concentration . CD14 has been shown to bind apoptotic cells, playing a role in the clearance of these cells from the body .
The primary function of CD14 is to recognize and bind LPS, facilitating the clearance of Gram-negative pathogens from the body . Upon binding to LPS, CD14 initiates a signaling cascade that results in the upregulation of adhesion molecules and cytokine expression in monocytes and neutrophils . This process is essential for the activation and recruitment of immune cells to sites of infection.